FORMA Therapeutics
Anna Ericsson has extensive work experience in the pharmaceutical industry. Anna started their career as a Research Investigator at Bristol-Myers Squibb from 1996 to 1998. After that, they joined Abbott Bioresearch Center as a Senior Scientist III and worked there for 13 years, from 1998 to 2011. In 2012, they joined FORMA Therapeutics, Inc. as a Consultant for a few months, and later became a Senior Scientist. Finally, in 2015, they were promoted to Principal Scientist at FORMA Therapeutics, Inc.
Anna Ericsson obtained their Ph.D. degree in Organic Chemistry from Uppsala University, where they studied from 1990 to 1994.
FORMA Therapeutics
Forma Therapeutics (Nasdaq: FMTX) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.